Correspondence on: ?SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy'

被引：3
|
作者：
Soler, Maria Jose [1 ,2 ,4 ]
Cacha, Conxita Jacobs [1 ,2 ]
Anders, Hans-Joachim [3 ]
机构：
[1] Univ Autonoma Barcelona, Hosp Univ Vall Dhebron, Nephrol Dept, Barcelona, Spain
[2] Vall Dhebron Res Inst VHIR, Nephrol Res Grp, Barcelona, Spain
[3] Univ Munich, Nephrol Ctr, Med Clin & Policlin 4, Munich, Germany
[4] Vall Dhebron Univ Hosp, Nephrol, Barcelona, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2024年 / 83卷 / 06期
关键词：
Lupus Nephritis; Lupus Erythematosus; Systemic; Autoimmune Diseases;
D O I：
10.1136/ard-2023-225248
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e13 / e13
页数：1
相关论文
共 40 条
  • [21] Insights from sodium-glucose transport 2 (SGLT2) inhibitors treatment in patients with systemic lupus erythematosus
    Kenis, Irina
    Tayer-Shifman, Oshrat E.
    Bar-Ziv, Dorin
    Kabaha, Mohamad
    Pri-Paz-Basson, Yael
    Kivity, Shaye
    Cohen-Hagai, Keren
    Benchetrit, Sydney
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [22] Insights from sodium-glucose transport 2 (SGLT2) inhibitors treatment in patients with systemic lupus erythematosus
    Kenis, Irina
    Tayer-Shifman, Oshrat E.
    Bar-Ziv, Dorin
    Kabaha, Mohamad
    Pri-Paz-Basson, Yael
    Kivity, Shaye
    Cohen-Hagai, Keren
    Benchetrit, Sydney
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2071 - I2072
  • [23] Call for action in ANCA-associated vasculitis and lupus nephritis: promises and challenges of SGLT-2 inhibitors
    Saeemann, Marcus
    Kronbichler, Andreas
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (05) : 614 - 617
  • [24] The protective role of SGLT2 inhibitors on aortic aneurysm mediated by oxidative stress and inflammation in type 2 diabetes mellitus
    Zheng, Rujie
    Song, Wenjuan
    Lu, Jie
    Yuan, Mingyue
    Sun, Xiaotong
    Lu, Chengzhi
    CARDIOVASCULAR DIABETOLOGY, 2025, 24 (01)
  • [25] SGLT2 inhibitors protect palmitate-induced cardiomyocytes inflammation by increasing activation of AMPK and lipid oxidations
    Lee, K. -W.
    Jeon, J.
    Lee, H.
    Choi, S. -E.
    Kang, Y.
    Kim, T.
    Moon, H.
    Han, S.
    Kim, H.
    DIABETOLOGIA, 2019, 62 : S24 - S25
  • [26] Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling/Autophagy Hypothesis
    Packer, Milton
    CIRCULATION, 2022, 146 (18) : 1383 - 1405
  • [27] Effect of SGLT2 Inhibitors on Decreasing the Risk of Depression in Patients with Diabetes: A Nationwide Active- Comparator Cohort Study in Taiwan
    Kao, Ming-Jyun
    Yang, Hui-Wen
    To, Sheng-Yin
    Wen, Yuan-Liang
    Kao, Li-Ting
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 358 - 359
  • [28] Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists
    Winiarska, Agata
    Knysak, Monika
    Nabrdalik, Katarzyna
    Gumprecht, Janusz
    Stompor, Tomasz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [29] Activation of Cyclooxygenase-2 by ATF4 During Endoplasmic Reticulum Stress Regulates Kidney Podocyte Autophagy Induced by Lupus Nephritis
    Jin, Juan
    Zhao, Li
    Zou, Wenli
    Shen, Wei
    Zhang, Hongjuan
    He, Qiang
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 48 (02) : 753 - 764
  • [30] Increases in circulating levels of ketone bodies and cardiovascular protection with SGLT2 inhibitors: Is low-grade inflammation the neglected component?
    Prattichizzo, Francesco
    De Nigris, Valeria
    Micheloni, Stefano
    La Sala, Lucia
    Ceriello, Antonio
    DIABETES OBESITY & METABOLISM, 2018, 20 (11): : 2515 - 2522
1234